Our latest COVID-19 information - full Autumn programme of webinars now in place

Kate Smith

Kate Smith is currently Principal Scientist, Development Services, at BioReliance, UK, part of the Merck Group. In this position she is reponsible for providing technical supprt to both colleagues adn clients on the deign, execution and interpretation of viral clearance studies. Prior to transitioning into Development services Kate was responsible for managing the team involved in the preparatino of cell banks, viral seeds stocks and production of clinical lots of virus. .
Prior to joining BioReliance Kate was a Principal Group Leader in the Purification Development Group at Lonza Biologics, plc. She has more than 18 years experience in the development, scale-up, transfer and validation of purification processes for monoclonal antibodies and recombinant proteins from mammalian cell cultures. Her area of expertise is the design and management of Viral and DNA reduction studies used to support product safety.

Biotechnology for the Non-Biotechnologist Training Course

Biotechnology for the Non-Biotechnologist

14-16 Apr 2021

An ideal course for non-scientists and scientists who need to understand the basic theory, principles, techniques and potential of biotechnology.

Biotechnology for the Non-Biotechnologist Training Course

Biotechnology for the Non-Biotechnologist

21-23 Apr 2021

An ideal course for non-scientists and scientists who need to understand the basic theory, principles, techniques and potential of biotechnology.

Biotechnology for the Non-Biotechnologist Training Course

Biotechnology for the Non-Biotechnologist

29 Sep-1 Oct 2021

An ideal course for non-scientists and scientists who need to understand the basic theory, principles, techniques and potential of biotechnology.

Biotechnology for the Non-Biotechnologist Training Course

Biotechnology for the Non-Biotechnologist

6-8 Oct 2021

An ideal course for non-scientists and scientists who need to understand the basic theory, principles, techniques and potential of biotechnology.